McCormick stock holds analyst support as JP Morgan trims price target

McCormick & Company stock (ISIN US5797802064) is trading well below its peak levels, yet still enjoys key analyst support after JP Morgan lowered its price target to USD 62.00 on September 18, 2026 while maintaining an Overweight rating and highlighting upside potential from current prices.

JP Morgan trims target but keeps Overweight

According to GuruFocus on September 18, 2026, JP Morgan analyst Thomas Palmer reiterated his Overweight rating on McCormick & Company while cutting the firm’s price target from USD 63.00 to USD 62.00, a reduction of 1.59 percent that still implies notable upside from the current share price.

The same overview notes that McCormick shares were trading around USD 49.36 at the time of the JP Morgan note, meaning the new USD 62.00 target represents a roughly 25.7 percent potential gain if the stock were to reach that level, underscoring that the rating change is a fine-tuning rather than a fundamental downgrade of the investment case.

Stock performance lags the Dow despite upside

A performance review published by Yahoo Finance on September 18, 2026 highlights that McCormick stock has slipped 31.4 percent from its 52-week high of USD 72.41, reached on February 13, 2026, illustrating how far the share price has retreated from earlier levels.

The same analysis points out that McCormick shares are down 27.6 percent year to date and 25.6 percent over the past 52 weeks, compared with the Dow Jones Industrial Average’s gains of 7.7 percent year to date and 12.5 percent over the past year, making McCormick a notable underperformer relative to the blue-chip benchmark.

Despite this weak trailing performance, the article notes that McCormick still carries a consensus rating of Moderate Buy from 14 covering analysts and a mean price target of USD 61.00, which suggests about 22.7 percent upside from the current share price level and indicates that many analysts see room for recovery.

Valuation metrics point to discount

In its September 18, 2026 piece, GuruFocus also presents its proprietary GF Value estimate for McCormick at USD 81.49, compared with the contemporaneous share price of USD 49.36, implying that the stock was trading at a discount of approximately 39.4 percent to the platform’s intrinsic value calculation.

For investors, this gap between market price and valuation estimates is central to the current debate: on one hand, the sharp decline from the February 2026 high of USD 72.41 and the pronounced underperformance versus the Dow signal that sentiment has weakened; on the other hand, the Moderate Buy consensus, the JP Morgan Overweight rating and the GF Value pointing to nearly 40 percent undervaluation support the view that the stock may be mispriced if McCormick can deliver stable growth and margins.

Strategic risk from Unilever Foods deal scrutiny

Beyond valuation and ratings, a fresh regulatory development adds a layer of strategic risk to the McCormick story. As Ground News reported on September 19, 2026, the UK Competition and Markets Authority has launched a Phase 1 investigation into a planned merger between Unilever’s foods division and McCormick to assess whether the agreement could restrict competition in key condiment categories in the UK market.

The article explains that the regulator is examining a proposed transaction valued at around USD 44.8 billion that would combine Unilever’s food assets with McCormick’s spice and seasoning business, with a preliminary ruling expected by November 11, 2026; both companies have reportedly discussed selling brands such as Colman’s mustard to ease competition concerns, underscoring that the deal structure and potential remedies could materially shape McCormick’s future footprint in the European condiments segment.

For shareholders, the CMA probe represents a clear counter-factor to the bullish valuation narrative: while a successful combination with Unilever Foods could significantly expand McCormick’s scale and product portfolio, regulatory pressure may force concessions or even jeopardize the transaction, making deal execution and possible divestitures a key risk to monitor alongside the company’s operating performance.

Stock price and key metrics

According to recent trading data summarized in the analyst coverage, McCormick stock on the New York Stock Exchange has been changing hands close to USD 49 per share in mid-September 2026, with that level standing roughly one third below the 52-week high of USD 72.41 recorded on February 13, 2026 and reflecting the 27.6 percent year-to-date decline noted by the performance review.

The same context indicates that McCormick’s market capitalization at these price levels is in the multi-billion USD range and that daily volume regularly reaches several hundred thousand shares, underlining that, despite its underperformance, the stock remains a liquid consumer staples name with broad index and fund ownership.

McCormick stock at a crossroads

As of the latest completed trading day before September 19, 2026, McCormick stock thus presents a mixed picture: valuation tools such as the GF Value estimate of USD 81.49 versus a share price around USD 49.36 suggest that the stock may be significantly undervalued, and analyst views range from JP Morgan’s Overweight rating with a USD 62.00 target to a broader Moderate Buy consensus with a mean target of USD 61.00; at the same time, the pronounced underperformance versus the Dow and the CMA’s competition scrutiny of the Unilever Foods combination highlight that the path to realizing this implied upside is not free of risk.

More news and analyses on McCormick stock